Long-term efficacy analysis of the randomised, phase II TRYPHAENA cardiac safety study: Evaluating pertuzumab and trastuzumab plus standard neoadjuvant anthracycline-containing and anthracycline-free chemotherapy regimens in patients with HER2-positive early breast cancer
| Autor: | Schneeweiss, Andreas, Chia, Stephen, Hickish, Tamas, Harvey, Vernon, Eniu, Alexandru, Waldron-Lynch, Maeve, Eng-Wong, Jennifer, Kirk, Sarah, Cortés, Javier |
|---|---|
| Zdroj: | In European Journal of Cancer January 2018 89:27-35 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect